---
title: "\"Performance\" CT ENTERPRISE's net profit for the first nine months was USD 23.54 million, an increase of 4.5 times"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/265186917.md"
description: "CT ENTERPRISE announced its performance for the first nine months ending in September, with revenue of USD 431 million, an increase of 152.4% year-on-year; gross profit of USD 59.59 million, up 91.8%. It recorded a net profit of USD 23.54 million, a growth of 452.3%"
datetime: "2025-11-10T15:46:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265186917.md)
  - [en](https://longbridge.com/en/news/265186917.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265186917.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/265186917.md) | [English](https://longbridge.com/en/news/265186917.md)


# "Performance" CT ENTERPRISE's net profit for the first nine months was USD 23.54 million, an increase of 4.5 times

CT ENTERPRISE (03839.HK) announced its results for the first nine months ending in September, with revenue of USD 431 million, an increase of 152.4% year-on-year; gross profit of USD 59.59 million, up 91.8%. It recorded a net profit of USD 23.54 million, a growth of 452.3%

### 相關股票

- [CT ENTERPRISE (03839.HK)](https://longbridge.com/zh-HK/quote/03839.HK.md)

## 相關資訊與研究

- [Chia Tai Enterprises to Build New RMB28.9 Million Fermentation Facility in Henan](https://longbridge.com/zh-HK/news/279247728.md)
- [Chia Tai Forecasts Rise in 2025 Profit](https://longbridge.com/zh-HK/news/273363782.md)
- [South Korea exports rise at strongest pace in nearly four decades](https://longbridge.com/zh-HK/news/281273288.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-HK/news/281325910.md)
- [CICC Sticks to Its Buy Rating for C&D International Investment Group Ltd. (1908)](https://longbridge.com/zh-HK/news/280899096.md)